Long-Term Effects of Dietary Sodium Intake on Cytokines and Neurohormonal Activation in Patients With Recently Compensated Congestive Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 10, 2009, Pages 864-873

  Parrinello, Gaspare ^a   Di Pasquale, Pietro ^b   Licata, Giuseppe ^a   Torres, Daniele ^a   Giammanco, Marco ^b   Fasullo, Sergio ^b   Mezzero, Manuela ^a   Paterna, Salvatore ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Ospedale GF Ingrassia   (Italy)

Author keywords

Aldosterone; bioelectrical impedance; BNP; congestive heart failure; cytokines; furosemide; moderate sodium restriction; plasma renin activity

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; CHYMOSIN; CYTOKINE; DIGITALIS; FUROSEMIDE; INTERLEUKIN 10; INTERLEUKIN 6; NEUROHORMONE; NITRIC ACID DERIVATIVE; SODIUM; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ENZYME ACTIVATION; FEMALE; FLUID INTAKE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM INTAKE; SODIUM RESTRICTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; NEUROTRANSMITTER AGENTS; SODIUM, DIETARY; TIME FACTORS;

EID: 70450223349     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.06.002     Document Type: Article

References (56)

1. Sarli Issa V., Bacal F., Mangini S., et al. Hypertonic saline solution for renal failure prevention in patients decompensated heart failure. Arq Bras Cardiol 89 (2007) 228-232
2. Paterna S., Parrinello G., Amato P., et al. Tolerability and efficacy of high dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure. Adv Ther 16 (1999) 219-228
3. Paterna S., Parrinello G., Amato P., et al. Small-volume hypertonic saline solution and high-dosage furosemide in the treatment of refractory congestive heart failure. A pilot study. Clin Drugs Invest 19 (2000) 9-13
4. Paterna S., Fasullo S., and Di Pasquale P. High-dose torsemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug. Invest 25 (2005) 165-173
5. Paterna S., Di Pasquale P., Parrinello G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Failure 2 (2000) 305-313
6. Licata G., Di Pasquale P., Parrinelllo G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long term effects. Am Heart J 145 (2003) 459-466
7. Paterna S., Pasquale P.D., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. J Am Coll Cardiol 45 (2005) 1997-2003
8. Paterna S., Parrinello G., Fasullo S., Sarullo F.M., and Di Pasquale P. Normal sodium diet versus low sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clin Sci 114 (2008) 221-230
9. Rodeheffer RJ, Redfield MM. Congestive heart failure: diagnosis, evaluation, and surgical therapy. In: Murphy JG, ed. Mayo Clin Cardiol Rev 2000;55-74.
10. Paterna S., Parrinello G., Cannizzaro S., Fasullo S., Torres D., Sarulo F.M., and Di Pasquale P. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 103 (2009) 93-102
11. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
12. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe, I: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
13. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
14. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 (2004) 43-51
15. Cody R.J. Management of refractory congestive heart failure. Am J Cardiol 69 (1992) 141G-149G
16. Lorentz F.H. Ein neuer Konstitionsinde. Klin Wochenschr 8 (1929) 348-351
17. Bioelectrical impedance analysis in body composition measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, MD, December 12-14, 1994. Am J Clin Nutr 64 Suppl (1996) 387S-532S
18. Parrinello G., Paterna S., Di Pasquale P., Torres D., Fatta A., Mezzero M., et al. The usefulness of Bioelectrical Impedance Analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 14 (2008) 676-686
19. Leclercq C., and Ferro-Luzzi A. Total and domestic consumption of salt and their determinants in three regions of Italy. Eur J Clin Nutr 45 (1991) 151-159
20. Commission of the European Communities. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. Thirty-first series (1993), Office for Official Publications of the European Communities, Luxemburg
21. Yan T.A., Yan R.T., and Liu P.P. Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials. Ann Intern Med 142 (2005) 132-145
22. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. A report of the American College of Cardiology/American Heart Association task force in practice guidelines. Accessed October 26, 2004, at www.acc.org/clinica/guidelines/failure/hf_htm.
23. Nohria A., Lewis E., and Stevenson L.W. Medical management of advanced heart failure. JAMA 287 (2002) 628-640
24. Heer M., Baisch F., Kropp J., Gerzer R., and Drumme C. (2000) High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 278 (2000) F585-F595
25. Cohen H.W., Hailpern S.M., Fang J., Alderman M.H., et al. Sodium intake and mortality in the NHANES II follow up study. Am J Med 119 (2006) 275-2e7-275-e14
26. He F.J., and MacGregor G.A. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 22 (2007) 298-306
27. Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ 334 (2007) 885-888
28. Selektor Y., and Weber K.T. The salt-avid state of congestive heart failure revisited. Am J Med Sci 335 (2008) 209-218
29. Pickkers P., Dormans T.P.J., Russel F.G.M., et al. Direct vascular effects of furosemide in humans. Circulation 96 (1997) 1847-1852
30. Gabrielsen A., Bie P., Holstein-Rathlou N.H., et al. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 281 (2001) R459-R467
31. Damgaard M., Bie P., Friberg L., et al. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 290 (2006) 1294-1301
32. Braunwald E., Plauth H., and Morrow A. A method for the detection and quantification of impaired sodium excretion. Results of an oral sodium tolerance test in normal subjects and in patients with heart disease. Circulation 32 (1965) 223-231
33. Cody R.J., Covit A.B., Schaer G.L., Laragh J.H., Sealey J.E., Feldschuh J., GL, et al. Sodium and water balance in chronic congestive heart failure. J Clin Invest 77 (1986) 1441-1452
34. Hollander W., and Judson W.E. The relationship of cardiovascular and renal hemodynamic function to sodium excretion in patients with severe heart disease but without edema. J Clin Invest 35 (1956) 970-979
35. Proger S., Ginsberg E., and Magendantz H. The effects of the ingestion of excessive amounts of sodium chloride and water on patients with heart disease. Am Heart J 23 (1942) 555-566
36. Volpe M., Tritto C., DeLuca N., et al. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 88 (1993) 1620-1627
37. Weinfeld M.S., Chertow G.M., and Stevenson L.W. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138 (1999) 285-290
38. Gottlieb S.S., Abraham W., Butler J., Forman D.E., Loh E., Massie B.M., O'connor C.M., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8 (2002) 136-141
39. Geisberg C., and Butler J. Addressing the challenges of cardiorenal syndrome. Cleveland Clin J Med 73 (2006) 485-491
40. Dibbs Z., Kurrelmeyer K., Kalra D., et al. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians 111 (1999) 423-428
41. Torre-Amione G., Kapadia S., Benedict C.R., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
42. Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28 (1996) 964-971
43. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci 108 (2005) 205-213
44. Munger M.A., Johnson B., Amber I.J., et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77 (1996) 723-727
45. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive failure. Circulation 92 (1995) 1479-1486
46. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 391-398
47. Seta Y., Shan K., Bozkurt B., et al. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2 (1996) 243-249
48. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
49. Gheorghiade M., Filippatos G., De L.L., et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119 Suppl 1 (2006) S3-S10
50. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators (RALES). N Engl J Med 341 (1999) 709-717
51. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
52. Magga J., Martilla M., Mantymaa P., Vuolteenaho O., and Ruskuaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin-and phenylephrine-infused conscious rats. Endocrinology 134 (1994) 2505-2515
53. Schrier M.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
54. Neri Serneri G.G., Boddi M., Coppo M., et al. Evidence for the existence of a functional cardiac rennin angiotensin system in humans. Circulation 94 (1996) 1886-1893
55. Di Pasquale P., Sarullo M.F., and Paterna S. Novel Strategies: Challenge loop Diuretics and sodium management in heart failure-part I. Congestive Heart Fail 13 (2007) 93-98
56. Di Pasquale P., Sarullo M.F., and Paterna S. Novel strategies: challenge loop diuretics and sodium management in heart failure-part II. Congestive Heart Fail 13 (2007) 170-176